ARCHIVES

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

President Asks $600 Million For NCI In ’75; Research Grants Would Get $19 Million Hike

February 8, 1974

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Nixon Tells ACCC U.S., USSR Should Be Allies In War Against Cancer

April 11, 1986

N.J. Congressman Seeks Increase In Prevention Effort

March 10, 1978

Other DCT Concepts Approved By Board

February 26, 1988

With Flashing Lights, Heckling, and Folk Song, Avastin Sets New Tone for FDA Debates

July 1, 2011